These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2880943)
1. The background and chemistry of MDMA. Shulgin AT J Psychoactive Drugs; 1986; 18(4):291-304. PubMed ID: 2880943 [No Abstract] [Full Text] [Related]
2. MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California. J Psychoactive Drugs; 1986; 18(4):287-379. PubMed ID: 2880942 [No Abstract] [Full Text] [Related]
3. Subjective reports of the effects of MDMA in a clinical setting. Greer G; Tolbert R J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946 [No Abstract] [Full Text] [Related]
4. The scheduling of MDMA: a pharmacist's perspective. Riedlinger JE J Psychoactive Drugs; 1985; 17(3):167-71. PubMed ID: 2865343 [No Abstract] [Full Text] [Related]
5. MDMA and human sexual function. Buffum J; Moser C J Psychoactive Drugs; 1986; 18(4):355-9. PubMed ID: 2880951 [No Abstract] [Full Text] [Related]
7. Ecstacy: a review of MDMA and MDA. Climko RP; Roehrich H; Sweeney DR; Al-Razi J Int J Psychiatry Med; 1986-1987; 16(4):359-72. PubMed ID: 2881902 [TBL] [Abstract][Full Text] [Related]
8. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. Nichols DE J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944 [No Abstract] [Full Text] [Related]
9. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Peroutka SJ; Newman H; Harris H Neuropsychopharmacology; 1988 Dec; 1(4):273-7. PubMed ID: 2908020 [TBL] [Abstract][Full Text] [Related]
10. Designer drug confusion: a focus on MDMA. Beck J; Morgan PA J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058 [No Abstract] [Full Text] [Related]
11. [MDMA ("ecstasy"): a currently used drug in Spain]. Prat A; Montero M; Reig R; Sanz P Rev Clin Esp; 1991 Feb; 188(2):106-8. PubMed ID: 1675014 [No Abstract] [Full Text] [Related]
12. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine. Lorens SA; Hata N; Cabrera T; Hamilton ME NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039 [No Abstract] [Full Text] [Related]
13. Effects of amphetamine analogs on central nervous system neuropeptide systems. Hanson GR; Sonsalla P; Letter A; Merchant KM; Johnson M; Bush L; Gibb JW NIDA Res Monogr; 1989; 94():259-69. PubMed ID: 2481828 [No Abstract] [Full Text] [Related]
17. Information on "Ecstasy". Greer G; Strassman RJ Am J Psychiatry; 1985 Nov; 142(11):1391. PubMed ID: 2865906 [No Abstract] [Full Text] [Related]
18. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats. Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Battaglia G; Brooks BP; Kulsakdinun C; De Souza EB Eur J Pharmacol; 1988 Apr; 149(1-2):159-63. PubMed ID: 2899513 [TBL] [Abstract][Full Text] [Related]
20. Some considerations on the prevalence of MDMA use. Newmeyer JA J Psychoactive Drugs; 1986; 18(4):361-2. PubMed ID: 2880952 [No Abstract] [Full Text] [Related] [Next] [New Search]